Industry Research Reports
Home > Reports > Service & Software > Global Mammalian CDMO Service Market Insights, Forecast to 2030
Global Mammalian CDMO Service Market Insights, Forecast to 2030
Industry: Service & Software
Published Date: 2024-04-10
Pages: 154 Pages
Report ld: 2679910
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Mammalian CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Mammalian CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Mammalian CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Mammalian CDMO Service include Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Mammalian CDMO Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mammalian CDMO Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Mammalian CDMO Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mammalian CDMO Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Mammalian CDMO Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Mammalian CDMO Service revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, etc.
MARKET SEGMENTATION
By Company
- Cytovance Biologics
- 3P Bio
- AGC Biologics
- KBI Biopharma
- GTP Bioways
- Tanvex CDMO
- Samsung Biologics
- WuXi Biologics
- PlantForm Corporation
- Gedeon Richter
- Lonza
- Novartis
- Rentschler Biopharma SE
- Northway Biotech
- Boehringer Ingelheim
- Cambrex
- FUJIFILM Diosynth Biotechnologies
- GBI
- Scorpius BioManufacturing
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cell Line Development
- Genomic Analysis
- Process Development
- Analytical Services
- Formulation Development
- Manufacturing
- Others
Segment by Application
- Contract Research Organizations (CROs)
- Pharmaceutical
- Biotechnology Companies
- Government Agencies
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Mammalian CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian CDMO Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mammalian CDMO Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Line Development
1.2.3 Genomic Analysis
1.2.4 Process Development
1.2.5 Analytical Services
1.2.6 Formulation Development
1.2.7 Manufacturing
1.2.8 Others
1.3 Market by Application
1.3.1 Global Mammalian CDMO Service Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Contract Research Organizations (CROs)
1.3.3 Pharmaceutical
1.3.4 Biotechnology Companies
1.3.5 Government Agencies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian CDMO Service Market Perspective (2019-2030)
2.2 Global Mammalian CDMO Service Growth Trends by Region
2.2.1 Global Mammalian CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mammalian CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 Mammalian CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 Mammalian CDMO Service Market Dynamics
2.3.1 Mammalian CDMO Service Industry Trends
2.3.2 Mammalian CDMO Service Market Drivers
2.3.3 Mammalian CDMO Service Market Challenges
2.3.4 Mammalian CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Mammalian CDMO Service by Players
3.1.1 Global Mammalian CDMO Service Revenue by Players (2019-2024)
3.1.2 Global Mammalian CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global Mammalian CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Mammalian CDMO Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Mammalian CDMO Service Market Concentration Ratio
3.4.1 Global Mammalian CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian CDMO Service Revenue in 2023
3.5 Global Key Players of Mammalian CDMO Service Head office and Area Served
3.6 Global Key Players of Mammalian CDMO Service, Product and Application
3.7 Global Key Players of Mammalian CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian CDMO Service Breakdown Data by Type
4.1 Global Mammalian CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global Mammalian CDMO Service Forecasted Market Size by Type (2025-2030)
5 Mammalian CDMO Service Breakdown Data by Application
5.1 Global Mammalian CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global Mammalian CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mammalian CDMO Service Market Size (2019-2030)
6.2 North America Mammalian CDMO Service Market Size by Type
6.2.1 North America Mammalian CDMO Service Market Size by Type (2019-2024)
6.2.2 North America Mammalian CDMO Service Market Size by Type (2025-2030)
6.2.3 North America Mammalian CDMO Service Market Share by Type (2019-2030)
6.3 North America Mammalian CDMO Service Market Size by Application
6.3.1 North America Mammalian CDMO Service Market Size by Application (2019-2024)
6.3.2 North America Mammalian CDMO Service Market Size by Application (2025-2030)
6.3.3 North America Mammalian CDMO Service Market Share by Application (2019-2030)
6.4 North America Mammalian CDMO Service Market Size by Country
6.4.1 North America Mammalian CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Mammalian CDMO Service Market Size by Country (2019-2024)
6.4.3 North America Mammalian CDMO Service Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Mammalian CDMO Service Market Size (2019-2030)
7.2 Europe Mammalian CDMO Service Market Size by Type
7.2.1 Europe Mammalian CDMO Service Market Size by Type (2019-2024)
7.2.2 Europe Mammalian CDMO Service Market Size by Type (2025-2030)
7.2.3 Europe Mammalian CDMO Service Market Share by Type (2019-2030)
7.3 Europe Mammalian CDMO Service Market Size by Application
7.3.1 Europe Mammalian CDMO Service Market Size by Application (2019-2024)
7.3.2 Europe Mammalian CDMO Service Market Size by Application (2025-2030)
7.3.3 Europe Mammalian CDMO Service Market Share by Application (2019-2030)
7.4 Europe Mammalian CDMO Service Market Size by Country
7.4.1 Europe Mammalian CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Mammalian CDMO Service Market Size by Country (2019-2024)
7.4.3 Europe Mammalian CDMO Service Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries
8 China
8.1 China Mammalian CDMO Service Market Size (2019-2030)
8.2 China Mammalian CDMO Service Market Size by Type
8.2.1 China Mammalian CDMO Service Market Size by Type (2019-2024)
8.2.2 China Mammalian CDMO Service Market Size by Type (2025-2030)
8.2.3 China Mammalian CDMO Service Market Share by Type (2019-2030)
8.3 China Mammalian CDMO Service Market Size by Application
8.3.1 China Mammalian CDMO Service Market Size by Application (2019-2024)
8.3.2 China Mammalian CDMO Service Market Size by Application (2025-2030)
8.3.3 China Mammalian CDMO Service Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Mammalian CDMO Service Market Size (2019-2030)
9.2 Asia Mammalian CDMO Service Market Size by Type
9.2.1 Asia Mammalian CDMO Service Market Size by Type (2019-2024)
9.2.2 Asia Mammalian CDMO Service Market Size by Type (2025-2030)
9.2.3 Asia Mammalian CDMO Service Market Share by Type (2019-2030)
9.3 Asia Mammalian CDMO Service Market Size by Application
9.3.1 Asia Mammalian CDMO Service Market Size by Application (2019-2024)
9.3.2 Asia Mammalian CDMO Service Market Size by Application (2025-2030)
9.3.3 Asia Mammalian CDMO Service Market Share by Application (2019-2030)
9.4 Asia Mammalian CDMO Service Market Size by Region
9.4.1 Asia Mammalian CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Mammalian CDMO Service Market Size by Region (2019-2024)
9.4.3 Asia Mammalian CDMO Service Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Mammalian CDMO Service Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Mammalian CDMO Service Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cytovance Biologics
11.1.1 Cytovance Biologics Company Details
11.1.2 Cytovance Biologics Business Overview
11.1.3 Cytovance Biologics Mammalian CDMO Service Introduction
11.1.4 Cytovance Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.1.5 Cytovance Biologics Recent Development
11.2 3P Bio
11.2.1 3P Bio Company Details
11.2.2 3P Bio Business Overview
11.2.3 3P Bio Mammalian CDMO Service Introduction
11.2.4 3P Bio Revenue in Mammalian CDMO Service Business (2019-2024)
11.2.5 3P Bio Recent Development
11.3 AGC Biologics
11.3.1 AGC Biologics Company Details
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics Mammalian CDMO Service Introduction
11.3.4 AGC Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.3.5 AGC Biologics Recent Development
11.4 KBI Biopharma
11.4.1 KBI Biopharma Company Details
11.4.2 KBI Biopharma Business Overview
11.4.3 KBI Biopharma Mammalian CDMO Service Introduction
11.4.4 KBI Biopharma Revenue in Mammalian CDMO Service Business (2019-2024)
11.4.5 KBI Biopharma Recent Development
11.5 GTP Bioways
11.5.1 GTP Bioways Company Details
11.5.2 GTP Bioways Business Overview
11.5.3 GTP Bioways Mammalian CDMO Service Introduction
11.5.4 GTP Bioways Revenue in Mammalian CDMO Service Business (2019-2024)
11.5.5 GTP Bioways Recent Development
11.6 Tanvex CDMO
11.6.1 Tanvex CDMO Company Details
11.6.2 Tanvex CDMO Business Overview
11.6.3 Tanvex CDMO Mammalian CDMO Service Introduction
11.6.4 Tanvex CDMO Revenue in Mammalian CDMO Service Business (2019-2024)
11.6.5 Tanvex CDMO Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Details
11.7.2 Samsung Biologics Business Overview
11.7.3 Samsung Biologics Mammalian CDMO Service Introduction
11.7.4 Samsung Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.7.5 Samsung Biologics Recent Development
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Details
11.8.2 WuXi Biologics Business Overview
11.8.3 WuXi Biologics Mammalian CDMO Service Introduction
11.8.4 WuXi Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.8.5 WuXi Biologics Recent Development
11.9 PlantForm Corporation
11.9.1 PlantForm Corporation Company Details
11.9.2 PlantForm Corporation Business Overview
11.9.3 PlantForm Corporation Mammalian CDMO Service Introduction
11.9.4 PlantForm Corporation Revenue in Mammalian CDMO Service Business (2019-2024)
11.9.5 PlantForm Corporation Recent Development
11.10 Gedeon Richter
11.10.1 Gedeon Richter Company Details
11.10.2 Gedeon Richter Business Overview
11.10.3 Gedeon Richter Mammalian CDMO Service Introduction
11.10.4 Gedeon Richter Revenue in Mammalian CDMO Service Business (2019-2024)
11.10.5 Gedeon Richter Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Mammalian CDMO Service Introduction
11.11.4 Lonza Revenue in Mammalian CDMO Service Business (2019-2024)
11.11.5 Lonza Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Mammalian CDMO Service Introduction
11.12.4 Novartis Revenue in Mammalian CDMO Service Business (2019-2024)
11.12.5 Novartis Recent Development
11.13 Rentschler Biopharma SE
11.13.1 Rentschler Biopharma SE Company Details
11.13.2 Rentschler Biopharma SE Business Overview
11.13.3 Rentschler Biopharma SE Mammalian CDMO Service Introduction
11.13.4 Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2019-2024)
11.13.5 Rentschler Biopharma SE Recent Development
11.14 Northway Biotech
11.14.1 Northway Biotech Company Details
11.14.2 Northway Biotech Business Overview
11.14.3 Northway Biotech Mammalian CDMO Service Introduction
11.14.4 Northway Biotech Revenue in Mammalian CDMO Service Business (2019-2024)
11.14.5 Northway Biotech Recent Development
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Details
11.15.2 Boehringer Ingelheim Business Overview
11.15.3 Boehringer Ingelheim Mammalian CDMO Service Introduction
11.15.4 Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2019-2024)
11.15.5 Boehringer Ingelheim Recent Development
11.16 Cambrex
11.16.1 Cambrex Company Details
11.16.2 Cambrex Business Overview
11.16.3 Cambrex Mammalian CDMO Service Introduction
11.16.4 Cambrex Revenue in Mammalian CDMO Service Business (2019-2024)
11.16.5 Cambrex Recent Development
11.17 FUJIFILM Diosynth Biotechnologies
11.17.1 FUJIFILM Diosynth Biotechnologies Company Details
11.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.17.3 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Introduction
11.17.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2019-2024)
11.17.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.18 GBI
11.18.1 GBI Company Details
11.18.2 GBI Business Overview
11.18.3 GBI Mammalian CDMO Service Introduction
11.18.4 GBI Revenue in Mammalian CDMO Service Business (2019-2024)
11.18.5 GBI Recent Development
11.19 Scorpius BioManufacturing
11.19.1 Scorpius BioManufacturing Company Details
11.19.2 Scorpius BioManufacturing Business Overview
11.19.3 Scorpius BioManufacturing Mammalian CDMO Service Introduction
11.19.4 Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2019-2024)
11.19.5 Scorpius BioManufacturing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Mammalian CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cell Line Development
Table 3. Key Players of Genomic Analysis
Table 4. Key Players of Process Development
Table 5. Key Players of Analytical Services
Table 6. Key Players of Formulation Development
Table 7. Key Players of Manufacturing
Table 8. Key Players of Others
Table 9. Global Mammalian CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Mammalian CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Mammalian CDMO Service Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Mammalian CDMO Service Market Share by Region (2019-2024)
Table 13. Global Mammalian CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Mammalian CDMO Service Market Share by Region (2025-2030)
Table 15. Mammalian CDMO Service Market Trends
Table 16. Mammalian CDMO Service Market Drivers
Table 17. Mammalian CDMO Service Market Challenges
Table 18. Mammalian CDMO Service Market Restraints
Table 19. Global Mammalian CDMO Service Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Mammalian CDMO Service Market Share by Players (2019-2024)
Table 21. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2023)
Table 22. Global Mammalian CDMO Service Industry Ranking 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Mammalian CDMO Service Revenue (CR5 and HHI) & (2019-2024)
Table 24. Global Key Players of Mammalian CDMO Service, Headquarters and Area Served
Table 25. Global Key Players of Mammalian CDMO Service, Product and Application
Table 26. Global Key Players of Mammalian CDMO Service, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Mammalian CDMO Service Revenue Market Share by Type (2019-2024)
Table 30. Global Mammalian CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Mammalian CDMO Service Revenue Market Share by Type (2025-2030)
Table 32. Global Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Mammalian CDMO Service Revenue Market Share by Application (2019-2024)
Table 34. Global Mammalian CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Mammalian CDMO Service Revenue Market Share by Application (2025-2030)
Table 36. North America Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 37. North America Mammalian CDMO Service Market Size by Type (2025-2030) & (US$ Million)
Table 38. North America Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 39. North America Mammalian CDMO Service Market Size by Application (2025-2030) & (US$ Million)
Table 40. North America Mammalian CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. North America Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 42. North America Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 43. Europe Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 44. Europe Mammalian CDMO Service Market Size by Type (2025-2030) & (US$ Million)
Table 45. Europe Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 46. Europe Mammalian CDMO Service Market Size by Application (2025-2030) & (US$ Million)
Table 47. Europe Mammalian CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Europe Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 49. Europe Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 50. China Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 51. China Mammalian CDMO Service Market Size by Type (2025-2030) & (US$ Million)
Table 52. China Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 53. China Mammalian CDMO Service Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 55. Asia Mammalian CDMO Service Market Size by Type (2025-2030) & (US$ Million)
Table 56. Asia Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 57. Asia Mammalian CDMO Service Market Size by Application (2025-2030) & (US$ Million)
Table 58. Asia Mammalian CDMO Service Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 59. Asia Mammalian CDMO Service Market Size by Region (2019-2024) & (US$ Million)
Table 60. Asia Mammalian CDMO Service Market Size by Region (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Type (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Application (2025-2030) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Mammalian CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 66. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 68. Cytovance Biologics Company Details
Table 69. Cytovance Biologics Business Overview
Table 70. Cytovance Biologics Mammalian CDMO Service Product
Table 71. Cytovance Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 72. Cytovance Biologics Recent Development
Table 73. 3P Bio Company Details
Table 74. 3P Bio Business Overview
Table 75. 3P Bio Mammalian CDMO Service Product
Table 76. 3P Bio Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 77. 3P Bio Recent Development
Table 78. AGC Biologics Company Details
Table 79. AGC Biologics Business Overview
Table 80. AGC Biologics Mammalian CDMO Service Product
Table 81. AGC Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 82. AGC Biologics Recent Development
Table 83. KBI Biopharma Company Details
Table 84. KBI Biopharma Business Overview
Table 85. KBI Biopharma Mammalian CDMO Service Product
Table 86. KBI Biopharma Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 87. KBI Biopharma Recent Development
Table 88. GTP Bioways Company Details
Table 89. GTP Bioways Business Overview
Table 90. GTP Bioways Mammalian CDMO Service Product
Table 91. GTP Bioways Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 92. GTP Bioways Recent Development
Table 93. Tanvex CDMO Company Details
Table 94. Tanvex CDMO Business Overview
Table 95. Tanvex CDMO Mammalian CDMO Service Product
Table 96. Tanvex CDMO Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 97. Tanvex CDMO Recent Development
Table 98. Samsung Biologics Company Details
Table 99. Samsung Biologics Business Overview
Table 100. Samsung Biologics Mammalian CDMO Service Product
Table 101. Samsung Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 102. Samsung Biologics Recent Development
Table 103. WuXi Biologics Company Details
Table 104. WuXi Biologics Business Overview
Table 105. WuXi Biologics Mammalian CDMO Service Product
Table 106. WuXi Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 107. WuXi Biologics Recent Development
Table 108. PlantForm Corporation Company Details
Table 109. PlantForm Corporation Business Overview
Table 110. PlantForm Corporation Mammalian CDMO Service Product
Table 111. PlantForm Corporation Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 112. PlantForm Corporation Recent Development
Table 113. Gedeon Richter Company Details
Table 114. Gedeon Richter Business Overview
Table 115. Gedeon Richter Mammalian CDMO Service Product
Table 116. Gedeon Richter Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 117. Gedeon Richter Recent Development
Table 118. Lonza Company Details
Table 119. Lonza Business Overview
Table 120. Lonza Mammalian CDMO Service Product
Table 121. Lonza Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 122. Lonza Recent Development
Table 123. Novartis Company Details
Table 124. Novartis Business Overview
Table 125. Novartis Mammalian CDMO Service Product
Table 126. Novartis Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 127. Novartis Recent Development
Table 128. Rentschler Biopharma SE Company Details
Table 129. Rentschler Biopharma SE Business Overview
Table 130. Rentschler Biopharma SE Mammalian CDMO Service Product
Table 131. Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 132. Rentschler Biopharma SE Recent Development
Table 133. Northway Biotech Company Details
Table 134. Northway Biotech Business Overview
Table 135. Northway Biotech Mammalian CDMO Service Product
Table 136. Northway Biotech Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 137. Northway Biotech Recent Development
Table 138. Boehringer Ingelheim Company Details
Table 139. Boehringer Ingelheim Business Overview
Table 140. Boehringer Ingelheim Mammalian CDMO Service Product
Table 141. Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 142. Boehringer Ingelheim Recent Development
Table 143. Cambrex Company Details
Table 144. Cambrex Business Overview
Table 145. Cambrex Mammalian CDMO Service Product
Table 146. Cambrex Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 147. Cambrex Recent Development
Table 148. FUJIFILM Diosynth Biotechnologies Company Details
Table 149. FUJIFILM Diosynth Biotechnologies Business Overview
Table 150. FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Product
Table 151. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 152. FUJIFILM Diosynth Biotechnologies Recent Development
Table 153. GBI Company Details
Table 154. GBI Business Overview
Table 155. GBI Mammalian CDMO Service Product
Table 156. GBI Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 157. GBI Recent Development
Table 158. Scorpius BioManufacturing Company Details
Table 159. Scorpius BioManufacturing Business Overview
Table 160. Scorpius BioManufacturing Mammalian CDMO Service Product
Table 161. Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
Table 162. Scorpius BioManufacturing Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mammalian CDMO Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Mammalian CDMO Service Market Share by Type: 2023 VS 2030
Figure 3. Cell Line Development Features
Figure 4. Genomic Analysis Features
Figure 5. Process Development Features
Figure 6. Analytical Services Features
Figure 7. Formulation Development Features
Figure 8. Manufacturing Features
Figure 9. Others Features
Figure 10. Global Mammalian CDMO Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Mammalian CDMO Service Market Share by Application: 2023 VS 2030
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Pharmaceutical Case Studies
Figure 14. Biotechnology Companies Case Studies
Figure 15. Government Agencies Case Studies
Figure 16. Others Case Studies
Figure 17. Mammalian CDMO Service Report Years Considered
Figure 18. Global Mammalian CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Mammalian CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Mammalian CDMO Service Market Share by Region: 2023 VS 2030
Figure 21. Global Mammalian CDMO Service Market Share by Players in 2023
Figure 22. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Mammalian CDMO Service Revenue in 2023
Figure 24. North America Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Mammalian CDMO Service Market Share by Type (2019-2030)
Figure 26. North America Mammalian CDMO Service Market Share by Application (2019-2030)
Figure 27. North America Mammalian CDMO Service Market Share by Country (2019-2030)
Figure 28. United States Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Canada Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Mammalian CDMO Service Market Share by Type (2019-2030)
Figure 32. Europe Mammalian CDMO Service Market Share by Application (2019-2030)
Figure 33. Europe Mammalian CDMO Service Market Share by Country (2019-2030)
Figure 34. Germany Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. France Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. U.K. Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Italy Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Russia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. China Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. China Mammalian CDMO Service Market Share by Type (2019-2030)
Figure 42. China Mammalian CDMO Service Market Share by Application (2019-2030)
Figure 43. Asia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Asia Mammalian CDMO Service Market Share by Type (2019-2030)
Figure 45. Asia Mammalian CDMO Service Market Share by Application (2019-2030)
Figure 46. Asia Mammalian CDMO Service Market Share by Region (2019-2030)
Figure 47. Japan Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. South Korea Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. China Taiwan Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. India Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Australia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Mammalian CDMO Service Market Share by Type (2019-2030)
Figure 55. Middle East, Africa, and Latin America Mammalian CDMO Service Market Share by Application (2019-2030)
Figure 56. Middle East, Africa, and Latin America Mammalian CDMO Service Market Share by Country (2019-2030)
Figure 57. Brazil Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Mexico Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Turkey Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Saudi Arabia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. Israel Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. GCC Countries Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 63. Cytovance Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 64. 3P Bio Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 65. AGC Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 66. KBI Biopharma Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 67. GTP Bioways Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 68. Tanvex CDMO Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 69. Samsung Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 70. WuXi Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 71. PlantForm Corporation Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 72. Gedeon Richter Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 73. Lonza Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 74. Novartis Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 75. Rentschler Biopharma SE Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 76. Northway Biotech Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 77. Boehringer Ingelheim Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 78. Cambrex Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 79. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 80. GBI Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 81. Scorpius BioManufacturing Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Mammalian CDMO Service market?
The top companies in the global Mammalian CDMO Service market are Cytovance Biologics、3P Bio、AGC Biologics.
Related Reports
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 148
USD 4900.00
(Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 105
USD 4250.00
(Single User License)
Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 133
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 122
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 110
USD 4250.00
(Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 124
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 97
USD 2900.00
(Single User License)
Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-04-10
Pages: 126
USD 4350.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-10
Pages: 124
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 148
USD 4900.00 (Single User License)Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 105
USD 4250.00 (Single User License)Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 133
USD 3950.00 (Single User License)Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 122
USD 2900.00 (Single User License)Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 110
USD 4250.00 (Single User License)Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 124
USD 3950.00 (Single User License)Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 97
USD 2900.00 (Single User License)Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-04-10
Pages: 126
USD 4350.00 (Single User License)Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-10
Pages: 124
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now